发明名称 THE COMPOSITION COMPRISING A PURIFIED EXTRACT ISOLATED FROM PSEUDOLYSIMACHION ROTUNDUM VAR. SUBINTEGRUM CONTAINING ABUNDANT AMOUNT OF ACTIVE INGREDIENT OR THE COMPOUNDS ISOLATED THEREFROM, AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THE USE THEREOF
摘要 A composition comprising a purified extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient or the compounds isolated therefrom as an active ingredient for treating a chronic obstructive pulmonary disease and the use thereof. Inventive purified extract and compounds showed potent anti-COPD activity without beta-2-receptor agonistic response through various in vivo tests as well as in vitro test. Therefore, it can be used as the therapeutics or functional health food for treating and preventing chronic obstructive pulmonary disease (COPD).
申请公布号 US2016051612(A1) 申请公布日期 2016.02.25
申请号 US201414780503 申请日期 2014.04.09
申请人 YUNGJIN PHARMACEUTICAL CO., LTD. ;KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY 发明人 LEE Yongnam;YOO Ji-seok;SHIN Dae-hee;RYOO Byung-hwan;AHN Kyung Seop;OH Sei Ryang;LEE Hyeong Kyu;SHIN In Sik;KIM Doo Young;KWON Ok-Kyoung;SONG Hyuk Hwan;KIM Seung Hyung;LEE SuUi
分类号 A61K36/68;A61K31/192;A61K31/7048 主分类号 A61K36/68
代理机构 代理人
主权项 1. A pharmaceutical composition comprising the purified extract with the secondary fractionation (ATC2) containing 30-60% (w/w) verproside, 0.5-10% (w/w) veratric acid, 2-20% (w/w) catalposide, 1-10% (w/w) picroside II, 1-10% (w/w) isovanilloyl catalpol and 2-20% (w/w) 6-O-veratroyl catalpol based on the weight of total extract (100%) of Pseudolysimachion rotundum var subintegrum Pseudolysimachion rotundum var subintegrum or verproside to treat chronic obstructive pulmonary disease (COPD).
地址 Seoul KR